Medical Industry Feature   /     The Time Is Now: Early Diagnosis and Intervention in Alzheimer’s Disease

Subtitle
Duration
00:00:00
Publishing date
2024-12-02 00:00
Link
https://reachmd.com/programs/medical-industry-feature/the-time-is-now-early-diagnosis-and-intervention-in-alzheimers-disease/18019/
Contributors
Enclosures
https://reachmd.com/programs/medical-industry-feature/the-time-is-now-early-diagnosis-and-intervention-in-alzheimers-disease/18019/podcast/54309.mp3?partner=itunes
audio/mpeg

Shownotes

Host: Jennifer Caudle, DO
Guest: Lori Guyton, MD
Guest: Douglas Scharre, MD

Our understanding of the mechanisms underlying Alzheimer’s disease is growing, and these advances can help inform diagnosis and management strategies. In fact, as our understanding of Alzheimer’s disease evolves, our strategies to diagnose and manage the disease are changing to focus on early diagnosis and intervention.1 Joining Dr. Jennifer Caudle to discuss our current understanding of disease progression as well as the impact and benefit of diagnosing Alzheimer’s disease early are Drs. Douglas Scharre and Lori Guyton. Dr. Scharre is the Director of the Division of Cognitive Neurology at the Ohio State University Wexner Medical Center in Columbus, and Dr. Guyton is a practicing neurologist with Neurology of Southern Illinois in Herrin.

Reference:

  1. Atri A. The Alzheimer’s disease clinical spectrum: Diagnosis and management. Med Clin North Am. 2019;103:263-293.

© Eisai Inc. 2024. All Rights Reserved.
AD-M2123 November 2024